Clinical Evaluation of Cervical Ripening in the Outpatient Setting

  • STATUS
    Recruiting
  • participants needed
    200
  • sponsor
    Centro Hospitalar Lisboa Norte
Updated on 16 February 2024

Summary

A randomized controlled trial of mifepristone 200mg vs balloon catheter for cervical ripening.

Description

Artificial induction of labour is currently required in 25-30% of all pregnancies, in high-resource countries. While the pharmacological modifications to the collagen matrix of the cervix, that allow it to dilate (cervical ripening) occur spontaneously in many women, allowing labour to be induced with oxytocin, in others the process needs to be triggered artificially. Cervical ripening is traditionally accomplished with prostaglandins or mechanical agents, in processes that typically require 12-24 hours of hospital stay. More recently, a limited number of hospitals have shifted towards starting the process in house, but then allowing women to return home and be re-evaluated on the following day.

The main aims this study is to compare efficacy and patient satisfaction of mifepristone vs balloon catheter for cervical ripening.

Details
Condition Labor; Forced or Induced, Affecting Fetus or Newborn, Labor Onset and Length Abnormalities
Age 18years - 45years
Treatment Cervical ripening
Clinical Study IdentifierNCT04271722
SponsorCentro Hospitalar Lisboa Norte
Last Modified on16 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Pregnant woman scheduled for induction of labor
Age between 18 and 45 years
Understanding and capable to sign informed consent
Singleton pregnancy
Gestational age 37 0/7 weeks
Live fetus in cephalic presentation
Intact membranes
Bishop score < 6
Estimated fetal weight < 4500g
Without contraindication to vaginal delivery
No major fetal anomaly

Exclusion Criteria

Previous cesarean section or myomectomy
Hypertension
Diabetes
Thyroid disease
Maternal conditions with high risk of placental insufficiency
Clear my responses

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.